Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril in Patients Undergoing Autologous Bone Marrow/Stem Cell Transplantation
NCT00004230Phase 3Completed
- Sponsor
- Northwestern University
- Start
- Oct 1999
- Primary completion
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of captopril in not applicable; "lung injury" is not a specific disease (2 arms), sponsored by Northwestern University. Primary endpoints: Incidence of lung injury at 6 months and Surrogate lung injury prediction markers at 6 months. Started Oct 1999; status: completed.
02
Drugs
captopril
03
Conditions
not applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on NCT00004230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004230.